ScripsAmerica, Inc. (OTCMKTS:SCRC) a leading provider firm of a wide range of specialty prescription and OTC medical supplies and pharmaceuticals issued an update on recent trading activity in its stock. The company knows of no motive concerning to its operations that would result in the recent unusual price activity and volume in its stock.
It has not given any updates related to the extensive discussion of the Company’s business as reflected in the investor presentation and available on the ScripsAmerica’s website. The same thing is applicable to all other public disclosure that is available on the website or in SEC filings. In addition, the Company fully plans to reiterate all of the disclosures and comments at the upcoming second Annual Growth Capital Expo on April 13, 2015.
ScripsAmerica is a supplier company of prescription, nutraceutical and OTC drugs, delivering pharmaceutical offerings to a wide group of end customers across the health care industry. The end customers include home care agencies, government, retail pharmacies, hospitals and long-term care facilities.
On January 29, ScripsAmerica made a 52-week high of around $0.22 per share. Lately, it made a 52-week low of $0.066 a share. In simple words, some people noticed their investments reduce by close to 70% in a matter of two months. As a matter of fact, Penny stocks are naturally volatile but these sorts of declines are not that uncommon.
The unusual activity
The unusual price activity that comes with a massive volume sets an alert tone in the market. It is what happened with ScripsAmerica stock price. There is no obvious reason for the sharp crash. Most of the investors are positively baffled from the recent price movements as the crash was not a result of any filings, news, press release or a promotion. The lack of an apparent reason is resulting in a bit of speculation. In last trading session, the stock price of SCRC surged 16.74% to close at $0.0781.